QurCan Therapeutics fosters scientific creativity with pioneering nanotechnologies to accelerate advanced nanomedicines and improve patients’ quality of life. QurCan is focused on the discovery and development of breakthrough therapeutics enabled by its proprietary nanoparticle drug delivery technology called “TERP”. |
CNS-Penetrating TERP |
TERP technology solves major hurdles in genetic medicine development, including the immunogenicity, high liver accumulation and toxicity associated with the existing nanoparticle technologies, while facilitating non-immunogenic and selective tissue targeting of nucleotides and other biological molecules, particularly to brain and spleen. |
Spleen-Specific TERP |
We are committed to restoring health and transforming the lives of patients through the development of nanomedicine that requires the unique features of the TERP technology to address major unmet needs for the treatment of cancer and CNS diseases. |